Results 231 to 240 of about 27,639 (307)

Ichthyosiform Dermatoses

open access: yesJournal of Investigative Dermatology, 1973
openaire   +2 more sources

Putative lotilaner/milbemycin‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract Stevens‒Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe skin and mucocutaneous reaction, characterised by extensive epidermal necrosis and skin sloughing. Drugs are common triggers, with reactions to a number of classes reported.
Matt McHale   +3 more
wiley   +1 more source

Concurrent paraneoplastic dermatomyositis and Sweet syndrome

open access: yesJAAD Case Reports
Alyssa M. Jobe, BS   +5 more
doaj   +1 more source

Treatment patterns and outcomes in perineal primary vulvar cancer—a population‐based Swedish cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 11, Page 2265-2274, November 2026.
Perineal vulvar squamous cell carcinoma was identified in 147 of 571 cases. Owing to the anatomical proximity of these tumors to the anus, treatment selection may present considerable clinical challenges. The majority of patients (53%) underwent surgical treatment alone, whereas 23% received surgery combined with adjuvant radiotherapy and 24% were ...
Karin Kjölhede   +4 more
wiley   +1 more source

Discoid Lupus Erythematosus in Genital Skin: A Case Report and Review of the Literature

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 11, Page 1000-1006, November 2026.
ABSTRACT Background Discoid lupus erythematosus (DLE) represents the most common variant of chronic cutaneous lupus erythematosus, a skin‐specific autoimmune disorder within the broader lupus erythematosus spectrum Clinically, DLE is characterized by erythematous, scaly plaques with areas of hyperpigmentation.
Ala' Abu‐Dayeh   +2 more
wiley   +1 more source

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 11, Page 1042-1050, November 2026.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy